PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 223 filers reported holding PDL BIOPHARMA INC in Q4 2013. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $141,000 | +31.8% | 56,911 | +21.0% | 0.01% | +20.0% |
| Q1 2017 | $107,000 | -60.8% | 47,018 | -46.0% | 0.01% | -68.8% |
| Q2 2016 | $273,000 | -19.2% | 87,024 | -14.3% | 0.02% | -30.4% |
| Q1 2016 | $338,000 | -28.2% | 101,526 | -23.7% | 0.02% | -28.1% |
| Q4 2015 | $471,000 | +74.4% | 133,036 | +147.9% | 0.03% | +100.0% |
| Q3 2015 | $270,000 | -90.6% | 53,670 | -86.9% | 0.02% | -90.9% |
| Q1 2015 | $2,872,000 | +92.1% | 408,245 | +110.6% | 0.18% | +44.3% |
| Q4 2014 | $1,495,000 | +83.0% | 193,879 | +77.2% | 0.12% | +121.8% |
| Q3 2014 | $817,000 | +455.8% | 109,403 | +516.9% | 0.06% | +111.5% |
| Q1 2014 | $147,000 | -89.4% | 17,734 | -89.2% | 0.03% | -85.6% |
| Q4 2013 | $1,388,000 | +634.4% | 164,512 | +571.6% | 0.18% | +542.9% |
| Q2 2013 | $189,000 | – | 24,494 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |